1. Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence of Ascites and Variceal Progression in Cirrhosis 
Luigi Bolondi, Fabio Piscaglia, Angelo Gatta, Francesco Salerno, Mauro Bernardi, Antonio Ascione, Oscar Ferraù, David Sacerdoti, Stefania Visentin, Franco Trevisani, Roberto Mazzanti, Gabriele Donati, Umberto Arena, Paolo Gentilini 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 11, Pages (November 2006)
DOI: /j.cgh
Copyright © 2006 AGA Institute Terms and Conditions

2. Figure 1
Patient flow after randomization. hcc, hepatocellular carcinoma; Dev., development of.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

3. Figure 2
Probability of remaining free from any end point (onset of ascites, development of esophageal varices, or progression of F1 varices) in patients receiving placebo (, group A, n = 51) or Kcanrenoate (•, group B, n = 47). The difference between the groups is statistically significant (P = .048).
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions